|
Home
This page provides key facts and general information
about avian influenza (bird flu) and one type
of bird flu, called avian influenza A (H5N1),
that has caused infections in birds in Asia and
Europe and in humans in Asia and other countries.
Avian
Influenza (Bird Flu), Avian influenza in birds
Human
infection with avian influenza viruses
Avian
Influenza A (H5N1)
Avian
influenza A (H5N1) outbreaks
Human
health risks during the H5N1 outbreak
Treatment
and vaccination for H5N1 virus in humans
Avian Influenza (Bird Flu) H5N1 , Avian influenza
in birds: |
Avian influenza is an infection caused by avian
(bird) influenza (flu) viruses. These influenza
viruses occur naturally among birds. Wild birds
worldwide carry the viruses in their intestines,
but usually do not get sick from them. However,
avian influenza is very contagious among birds
and can make some domesticated birds, including
chickens, ducks, and turkeys, very sick and kill
them.
Infected birds shed influenza virus in their
saliva, nasal secretions, and feces. Susceptible
birds become infected when they have contact with
contaminated secretions or excretions or with
surfaces that are contaminated with secretions
or excretions from infected birds. Domesticated
birds may become infected with avian influenza
virus through direct contact with infected waterfowl
or other infected poultry, or through contact
with surfaces (such as dirt or cages) or materials
(such as water or feed) that have been contaminated
with the virus.
Infection with avian influenza viruses in domestic
poultry causes two main forms of disease that
are distinguished by low and high extremes of
virulence. The low pathogenic form
may go undetected and usually causes only mild
symptoms (such as ruffled feathers and a drop
in egg production). However, the highly pathogenic
form spreads more rapidly through flocks of poultry.
This form may cause disease that affects multiple
internal organs and has a mortality rate that
can reach 90-100% often within 48 hours.
Top
Human infection with avian influenza viruses:
There are many different subtypes of type A influenza
viruses. These subtypes differ because of changes
in certain proteins on the surface of the influenza
A virus (hemagglutinin [HA] and neuraminidase
[NA] proteins). There are 16 known HA subtypes
and 9 known NA subtypes of influenza A viruses.
Many different combinations of HA and NA proteins
are possible. Each combination represents a different
subtype. All known subtypes of influenza A viruses
can be found in birds.
Usually, avian influenza virus refers
to influenza A viruses found chiefly in birds,
but infections with these viruses can occur in
humans. The risk from avian influenza is generally
low to most people, because the viruses do not
usually infect humans. However, confirmed cases
of human infection from several subtypes of avian
influenza infection have been reported since 1997.
Most cases of avian influenza infection in humans
have resulted from contact with infected poultry
(e.g., domesticated chicken, ducks, and turkeys)
or surfaces contaminated with secretion/excretions
from infected birds. The spread of avian influenza
viruses from one ill person to another has been
reported very rarely, and transmission has not
been observed to continue beyond one person.
Human influenza virus usually refers
to those subtypes that spread widely among humans.
There are only three known A subtypes of influenza
viruses (H1N1, H1N2, and H3N2) currently circulating
among humans. It is likely that some genetic parts
of current human influenza A viruses came from
birds originally. Influenza A viruses are constantly
changing, and they might adapt over time to infect
and spread among humans.
During an outbreak of avian influenza among poultry,
there is a possible risk to people who have contact
with infected birds or surfaces that have been
contaminated with secretions or excretions from
infected birds.
Symptoms of avian influenza in humans have ranged
from typical human influenza-like symptoms (e.g.,
fever, cough, sore throat, and muscle aches) to
eye infections, pneumonia, severe respiratory
diseases (such as acute respiratory distress),
and other severe and life-threatening complications.
The symptoms of avian influenza may depend on
which virus caused the infection.
Studies done in laboratories suggest that some
of the prescription medicines approved in the
United States for human influenza viruses should
work in treating avian influenza infection in
humans. However, influenza viruses can become
resistant to these drugs, so these medications
may not always work. Additional studies are needed
to demonstrate the effectiveness of these medicines.
Top
Avian Influenza A (H5N1):
Influenza A (H5N1) virus also called H5N1
virus is an influenza A virus subtype
that occurs mainly in birds, is highly contagious
among birds, and can be deadly to them. H5N1 virus
does not usually infect people, but infections
with these viruses have occurred in humans. Most
of these cases have resulted from people having
direct or close contact with H5N1-infected poultry
or H5N1-contaminated surfaces.
Top
Avian influenza A (H5N1) outbreaks
From The Center For Disease Control And Prevention
Website
Human H5N1 Cases
Human Cases: Summary of Current Situation
Since January, 2004 World Health Organization
has reported human cases of avian influenza A
(H5N1) in the following countries:
| East Asia and the
Pacific: |
Europe & Eurasia:
|
Cambodia
China
Indonesia
Thailand
Vietnam |
Azerbaijan
Turkey
Near East:
Egypt
Iraq |
For additional information about these reports,
visit the
World Health Organization Web Site.
Updated April 3, 2006
Top
Human health risks during the H5N1 outbreak:
Of the few avian influenza viruses that have crossed
the species barrier to infect humans, H5N1 has
caused the largest number of detected cases of
severe disease and death in humans. In the current
outbreaks in Asia and Europe more than half of
those infected with the virus have died. Most
cases have occurred in previously healthy children
and young adults. However, it is possible that
the only cases currently being reported are those
in the most severely ill people, and that the
full range of illness caused by the H5N1 virus
has not yet been defined.
So far, the spread of H5N1 virus from person
to person has been limited and has not continued
beyond one person. Nonetheless, because all influenza
viruses have the ability to change, scientists
are concerned that H5N1 virus one day could be
able to infect humans and spread easily from one
person to another. Because these viruses do not
commonly infect humans, there is little or no
immune protection against them in the human population.
If H5N1 virus were to gain the capacity to spread
easily from person to person, an influenza pandemic
(worldwide outbreak of disease) could begin.
No one can predict when a pandemic might occur.
However, experts from around the world are watching
the H5N1 situation in Asia and Europe very closely
and are preparing for the possibility that the
virus may begin to spread more easily and widely
from person to person.
Top
Treatment and vaccination for H5N1 virus
in humans:
The H5N1 virus that has caused human illness and
death in Asia is resistant to amantadine and rimantadine,
two antiviral medications commonly used for influenza.
Two other antiviral medications, oseltamavir and
zanamavir, would probably work to treat influenza
caused by H5N1 virus, but additional studies still
need to be done to demonstrate their effectiveness.
There currently is no commercially available
vaccine to protect humans against H5N1 virus that
is being seen in Asia and Europe. However, vaccine
development efforts are taking place. Research
studies to test a vaccine to protect humans against
H5N1 virus began in April 2005, and a series of
clinical trials is under way. For more information
about H5N1 vaccine development process, visit
the National Institutes of Health website.
Top
|